Indexed keywords
CLINDAMYCIN;
COTRIMOXAZOLE;
FUROSEMIDE;
INSULIN;
LISINOPRIL;
METOPROLOL SUCCINATE;
POTASSIUM;
ANTIINFECTIVE AGENT;
ADULT;
CASE REPORT;
CELLULITIS;
CHRONIC KIDNEY DISEASE;
CLINICAL FEATURE;
DISEASE DURATION;
DISEASE EXACERBATION;
DRUG EFFECT;
DRUG SAFETY;
DRUG WITHDRAWAL;
HEART EJECTION FRACTION;
HEART FAILURE;
HEART INFARCTION;
HUMAN;
HYPERKALEMIA;
HYPERTENSION;
MALE;
MIDDLE AGED;
NON INSULIN DEPENDENT DIABETES MELLITUS;
PHYSICAL EXAMINATION;
POTASSIUM BLOOD LEVEL;
PRIORITY JOURNAL;
REVIEW;
TREATMENT DURATION;
WEAKNESS;
BLOOD;
CHEMICALLY INDUCED;
ANTI-INFECTIVE AGENTS;
CELLULITIS;
HUMANS;
HYPERKALEMIA;
MALE;
MIDDLE AGED;
POTASSIUM;
TRIMETHOPRIM, SULFAMETHOXAZOLE DRUG COMBINATION;
1
84949298503
Centers for Medicare & Medicaid Services. Clinical laboratory fee schedule Accessed November, 17, 2015
Centers for Medicare & Medicaid Services. Clinical laboratory fee schedule. http://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/ClinicalLabFeeSched/index.html. Accessed November, 17, 2015.
2
77955871521
A physiologic-based approach to the evaluation of a patient with hyperkalemia
Palmer BF. A physiologic-based approach to the evaluation of a patient with hyperkalemia. Am J Kidney Dis. 2010;56(2):387-393.
(2010)
Am J Kidney Dis. , vol.56
, Issue.2
, pp. 387-393
Palmer, B.F.1
3
84864801182
Prevalence and factors associated with hyperkalemia in predialy-sis patients followed in a low-clearance clinic
Sarafidis PA, Blacklock R, Wood E, et al. Prevalence and factors associated with hyperkalemia in predialy-sis patients followed in a low-clearance clinic. Clin J Am Soc Nephrol. 2012;7(8):1234-1241.
(2012)
Clin J Am Soc Nephrol. , vol.7
, Issue.8
, pp. 1234-1241
Sarafidis, P.A.1
Blacklock, R.2
Wood, E.3
4
84908248239
Management of hyperkalaemia in chronic kidney disease
Kovesdy CP. Management of hyperkalaemia in chronic kidney disease. Nat Rev Nephrol. 2014;10 (11):653-662.
(2014)
Nat Rev Nephrol. , vol.10
, Issue.11
, pp. 653-662
Kovesdy, C.P.1
5
0029445164
Renal complications associated with use of nonsteroidal anti-inflammatory agents
Palmer BF. Renal complications associated with use of nonsteroidal anti-inflammatory agents. J Investig Med. 1995;43(6):516-533.
(1995)
J Investig Med. , vol.43
, Issue.6
, pp. 516-533
Palmer, B.F.1
6
84930453804
Regulation of potassium homeostasis
Palmer BF. Regulation of potassium homeostasis. Clin J Am Soc Nephrol. 2015;10(6):1050-1060.
(2015)
Clin J Am Soc Nephrol. , vol.10
, Issue.6
, pp. 1050-1060
Palmer, B.F.1
7
3442888821
Managing hyperkalemia caused by inhibitors of the renin-angiotensin-aldosterone system
Palmer BF. Managing hyperkalemia caused by inhibitors of the renin-angiotensin-aldosterone system. N Engl J Med. 2004;351(6):585-592.
(2004)
N Engl J Med. , vol.351
, Issue.6
, pp. 585-592
Palmer, B.F.1
8
0034113343
Trimethoprim-induced hyperkalaemia
Perazella MA. Trimethoprim-induced hyperkalaemia. Drug Saf. 2000;22(3):227-236.
(2000)
Drug Saf. , vol.22
, Issue.3
, pp. 227-236
Perazella, M.A.1
9
84938836695
Electrolyte and acid-base disturbances in patients with diabetes mellitus
Palmer BF, Clegg DJ. Electrolyte and acid-base disturbances in patients with diabetes mellitus. N Engl J Med. 2015;373(6):548-559.
(2015)
N Engl J Med. , vol.373
, Issue.6
, pp. 548-559
Palmer, B.F.1
Clegg, D.J.2
10
42549117080
Retrospective review of the frequency of ECG changes in hyperkalemia
Montague BT, Ouellette JR, Buller GK. Retrospective review of the frequency of ECG changes in hyperkalemia. Clin J Am Soc Nephrol. 2008;3(2):324-330.
(2008)
Clin J Am Soc Nephrol. , vol.3
, Issue.2
, pp. 324-330
Montague, B.T.1
Ouellette, J.R.2
Buller, G.K.3
